PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB

The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof. La présente invention concerne des com...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ELBAZ, FRANTZ, STINGELIN, DORIS, KOCHHAR, CHARU, BOCK, MICHAELA ANNA MARIA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof. La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci.